BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34652254)

  • 1. Fetal therapy of LUTO (lower urinary tract obstruction) - a follow-up observational study.
    Keil C; Bedei I; Sommer L; Koemhoff M; Axt-Fliedner R; Köhler S; Weber S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8536-8543. PubMed ID: 34652254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex
    Strizek B; Gottschalk I; Recker F; Weber E; Flöck A; Gembruch U; Geipel A; Berg C
    Arch Gynecol Obstet; 2020 Jul; 302(1):133-140. PubMed ID: 32449061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal renal parenchymal area as a predictor of early end-stage renal disease in children with vesicoamniotic shunting for lower urinary tract obstruction.
    Moscardi PRM; Katsoufis CP; Jahromi M; Blachman-Braun R; DeFreitas MJ; Kozakowski K; Castellan M; Labbie A; Gosalbez R; Alam A
    J Pediatr Urol; 2018 Aug; 14(4):320.e1-320.e6. PubMed ID: 30093259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting.
    Ruano R; Sananes N; Sangi-Haghpeykar H; Hernandez-Ruano S; Moog R; Becmeur F; Zaloszyc A; Giron AM; Morin B; Favre R
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):452-8. PubMed ID: 25157756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy.
    Nassr AA; Shamshirsaz AA; Erfani H; Espinoza J; Sanz Cortes M; Koh CJ; Roth DR; Angelo JR; Mandy GT; Braun MC; Ruano R; Belfort MA
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):500-505. PubMed ID: 30977189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of fetuses with lower urinary tract obstruction treated with vesicoamniotic shunt: a single-institution experience.
    Ethun CG; Zamora IJ; Roth DR; Kale A; Cisek L; Belfort MA; Haeri S; Ruano R; Welty SE; Cassady CI; Olutoye OO; Cass DL
    J Pediatr Surg; 2013 May; 48(5):956-62. PubMed ID: 23701767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower urinary tract obstruction: fetal intervention based on prenatal staging.
    Ruano R; Dunn T; Braun MC; Angelo JR; Safdar A
    Pediatr Nephrol; 2017 Oct; 32(10):1871-1878. PubMed ID: 28730376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center outcome analysis of 46 fetuses with megacystis after intrauterine vesico-amniotic shunting with the Somatex®intrauterine shunt.
    Gottschalk I; Berg C; Menzel T; Abel JS; Kribs A; Dübbers M; Kohaut J; Weber LT; Taylan C; Habbig S; Liebau MC; Boemers TM; Weber EC
    Arch Gynecol Obstet; 2024 Jan; 309(1):145-158. PubMed ID: 36604332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicoamniotic Shunting before 17 + 0 Weeks in Fetuses with Lower Urinary Tract Obstruction (LUTO): Comparison of Somatex vs. Harrison Shunt Systems.
    Strizek B; Spicher T; Gottschalk I; Böckenhoff P; Simonini C; Berg C; Gembruch U; Geipel A
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining and predicting 'intrauterine fetal renal failure' in congenital lower urinary tract obstruction.
    Ruano R; Safdar A; Au J; Koh CJ; Gargollo P; Shamshirsaz AA; Espinoza J; Cass DL; Olutoye OO; Olutoye OA; Welty S; Roth DR; Belfort MA; Braun MC
    Pediatr Nephrol; 2016 Apr; 31(4):605-12. PubMed ID: 26525197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesico-amniotic shunt insertion prior to the completion of 16 weeks results in improved preservation of renal function in surviving fetuses with isolated severe lower urinary tract obstruction (LUTO).
    Kohl T; Fimmers R; Axt-Fliedner R; Degenhardt J; Brückmann M
    J Pediatr Urol; 2022 Apr; 18(2):116-126. PubMed ID: 35123910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial.
    Morris RK; Malin GL; Quinlan-Jones E; Middleton LJ; Hemming K; Burke D; Daniels JP; Khan KS; Deeks J; Kilby MD;
    Lancet; 2013 Nov; 382(9903):1496-506. PubMed ID: 23953766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal staging of congenital lower urinary tract obstruction.
    Fontanella F; van Scheltema PNA; Duin L; Cohen-Overbeek TE; Pajkrt E; Bekker MN; Willekes C; Oepkes D; Bilardo CM
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):520-524. PubMed ID: 29978555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Sequential Urine Analysis when Selecting Candidates for Vesicoamniotic Shunting in Lower Urinary Tract Obstruction.
    Koch A; Favre R; Weingertner AS; Zaloszyc A; Kohler M; Guerra F; Rosenblatt J; Muller F; Dreux S; Sananès N
    Fetal Diagn Ther; 2021; 48(4):265-271. PubMed ID: 33756463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction.
    Morris RK; Malin GL; Quinlan-Jones E; Middleton LJ; Diwakar L; Hemming K; Burke D; Daniels J; Denny E; Barton P; Roberts TE; Khan KS; Deeks JJ; Kilby MD
    Health Technol Assess; 2013 Dec; 17(59):1-232. PubMed ID: 24331029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental Outcome in Infants with Lower Urinary Tract Obstruction Based on Different Degrees of Severity.
    Monteiro S; Nassr AA; Yun PS; Voigt R; Koh CJ; Roth DR; Braun M; Angelo J; Moscardo I; Espinoza J; Shamshirsaz AA; Belfort M; Ruano R; Sanz Cortes M
    Fetal Diagn Ther; 2020; 47(8):587-596. PubMed ID: 32146466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital lower urinary tract obstruction with spontaneous fetal bladder rupture due to posterior urethral valves: a case report.
    Adriaenssens M; De Boe V
    J Med Case Rep; 2023 Oct; 17(1):445. PubMed ID: 37875965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal surgical treatment and complications following intrauterine vesicoamniotic shunting with the SOMATEX® intrauterine shunt. A single center experience.
    Kohaut J; Fischer-Mertens J; Cernaianu G; Schulten D; Holtkamp G; Kohl S; Habbig S; Klein R; Kribs A; Gottschalk I; Berg C; Dübbers M
    J Pediatr Urol; 2023 Oct; 19(5):567.e1-567.e6. PubMed ID: 37451915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal Outcomes of Fetal Lower Urinary Tract Obstruction After Vesicoamniotic Shunting Using a Double-Basket Catheter.
    Jeong BD; Won HS; Lee MY
    J Ultrasound Med; 2018 Sep; 37(9):2147-2156. PubMed ID: 29498072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal cardiac findings and hemodynamic changes associated with severe lower urinary tract obstruction in utero.
    Cohen J; Levasseur S; Simpson L; Miller R; Freud L
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):780-785. PubMed ID: 30908816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.